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The cellular network is highly interconnected. Pathways merge and diverge. They proceed through shared
proteins and may change directions. How are cellular pathways controlled and their directions decided,
coded, and read? These questions become particularly acute when we consider that a small number of path-
ways, such as signaling pathways that regulate cell fates, cell proliferation, and cell death in development, are
extensively exploited. This review focuses on these signaling questions from the structural standpoint and
discusses the literature in this light. All co-occurring allosteric events (including posttranslational modifica-
tions, pathogen binding, and gain-of-function mutations) collectively tag the protein functional site with a
unique barcode. The barcode shape is read by an interacting molecule, which transmits the signal. A confor-
mational barcode provides an intracellular address label, which selectively favors binding to one partner and
quenches binding to others, and, in this way, determines the pathway direction, and, eventually, the cell’s
response and fate.Signaling controls cell actions (Clevers and Nusse, 2012; De
Trez, 2012; Herr et al., 2012; Ramos and Camargo, 2012), and
signaling cannot take place without allostery (Biter et al., 2012;
Chennubhotla et al., 2008; Cui and Karplus, 2008; Dixit and Ver-
khivker, 2011; Endres et al., 2011; Goodey and Benkovic, 2008;
Kenakin and Miller, 2010; Korkmaz et al., 2012; Lesne et al.,
2012; Long and Bru¨schweiler, 2011a; Nussinov et al., 2012; Pan-
dini et al., 2012; Piwonski et al., 2012; Selvaratnam et al., 2011;
Tsai et al., 2009a; Tsai and Nussinov, 2011; Tzeng and Kalodi-
mos, 2011; Whitley and Lee, 2009; Zhuravlev and Papoian,
2010). Communications from the extracellular space, via extra-
membranous domains, the membrane, and the cytoplasm, to,
in, and out of the nucleus are all accomplished with the help of
allosteric propagation. Via a conformational biasing mechanism,
allostery controls pathway divergence and unification; governs
pathway branching and direction in scaffolding proteins, as in
the case of the yeast mitogen-activated protein kinase (MAPK)
(Zalatan et al., 2012); and coordinates molecular machines and
multienzyme complexes (Nussinov et al., 2013a).
How are multiple co-occurring allosteric events acting on a
protein (or RNA or DNA) read in the cell? While frequently over-
looked, this question is of fundamental importance because, at
any point in time, multiple co-occurring allosteric events take
place (e.g., a protein binds multiple partners in a complex,
undergoes allosteric posttranslational modifications [PTMs],
and interacts with ions and with the membrane). Collectively,
available data suggest that allostery exerts conformational con-
trol over cellular pathways and the network to decide cell
responses; and it performs these tasks by tagging protein bind-
ing sites with barcode labels, where a barcode is a composite of
all concomitant allosteric actions on the given protein.
To date, studies of signaling on the conformational level have
largely focused on individual molecules and a single allostericStructureevent. However, in living cells, signaling proceeds across path-
ways and pathway crosstalks, which emanates from and leads
to simultaneous allosteric actions (Gunasekaran et al., 2004;
Kar et al., 2010; Korcsma´ros et al., 2010). The complexity of
the cellular network is immense: pathways can integrate and
branch and the signal they transmit may strengthen or weaken.
In the cell, virtually all pathways are interconnected. Cell re-
sponses reflect this network connectivity. Interconnectivity, unit-
ing, and partitioning takes place through proteins that are shared
by a number of pathways. These are typically signaling proteins
that can bind a large number of partners (Tsai et al., 2009b),
which raises questions such as (1) how does a shared protein
‘‘know’’ which partner to bind at any given time? (2) What
decides pathway branching, integration, and the consequent
change in direction of the signaling pathway? (3) How is the
signal coded, and how is it read? (4) Is there a unifying mecha-
nism through which signaling proteins communicate in environ-
ment- and cell type-dependent (and ligand-independent) ways?
When combined with orthosteric (i.e., binding site) PTMs, muta-
tions, and the physiological environment (i.e., ligand concentra-
tion, etc.), barcode labels, which reflect the composite of all
concurrent allosteric events, can help in the understanding of
physiological function, the mode of action of gain-of-function
mutations, and drug discovery. Such a barcode concept is
rooted in the free-energy landscape description of proteins (Fer-
reiro et al., 2011; Frauenfelder et al., 1991).
Here, our major premise is that prior allosteric events may
(partially) quench the coupling of the signaling protein to some
of its partners and favor others and, by so doing, direct the sig-
nals toward specific pathways. The collective effect of all co-
occurring allosteric actions (e.g., phosphorylation of a specific
set of serine and threonine residues) can provide intracellular
address labels, leading to a distinct receptor-binding site shape21, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1509
Figure 1. Posttranslational Phosphorylation of p53 Takes Place at
Numerous Serine and Threonine Residues, Providing Barcodes for
p53 Signaling
(A) Phosphorylation events in the N-terminal region mostly stabilize the p53
and lead to apoptosis. Several mutations in the core DNA-binding domain can
(allosterically, by shifting the equilibrium) destabilize p53, leading to COP9
degradation. Phosphorylation in the C-terminal region can increase p53
activity and p53 DNA-binding affinity. ‘‘Signalome’’ is the cell-signaling
network, consisting of highly connected functional modules (Ma’ayan et al.,
2005). The COP9 signalosome (CSN) is a conserved protein complex that
functions in the ubiquitin-proteasome pathway. It is a multisubunit protease
that regulates the activity of cullin-RING ligase. It removes the post-
translational modification of ubiquitin-like protein, Nedd8/Rub1, from the cullin
component of the ubiquitin E3 ligase (i.e., deneddylation). In addition, it is
associated with deubiquitination activity and protein kinase activities capable
of phosphorylating important signaling regulators. CSN is a key player in the
DNA-damage response, cell-cycle control, and gene expression (Wei and
Deng, 2003; Wei et al., 2008). The figure illustrates that PTMs (here, phos-
phorylation) at the functional sites (i.e., orthosteric PTMs in the body of the text)
can serve as barcodes. The N-terminal phosphorylation events are allosteric.
In this paper, we focus on allosteric barcodes.
(B) p53 is one of the most connected nodes in either the protein-protein
interaction network or the gene regulation network. The central circle repre-
sents both wild-type p53 and isoforms; the light brown circles are phosphor-
ylation events required for turning on/off specific p53-protein interactions. The
blue circles represent proteins interacting with p53. Note that the phosphor-
ylation of Ser15 and Ser20 blocks the p53-MDM2 interaction. The figure is
adapted with permission from Tsai et al., (2009b).
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PTMs, noncovalent binding, and allosteric (e.g., gain-of-func-
tion) mutational combinations. Simply put, each set of allosteric
events provides a distinct conformational barcode. Conforma-1510 Structure 21, September 3, 2013 ª2013 Elsevier Ltd All rights rtional barcodes may have short residence times; however, their
duration should be sufficiently long for recognition and binding
for the allosteric signal to go through. A signaling protein may
have many barcodes; each spells a specific function. Barcodes
are imprinted on receptors, scaffolding, and cytoskeleton pro-
teins, which are also allosteric. Collectively, barcodes can direct
signaling in the cell by specifying a distinct allosteric relay under
a specific set of conditions and, in this way, switch pathway
direction. If allostery is not at play, neither signal propagation
nor pathway switching will take place. Cheong et al. (2011)
analyzed the information transduction capacity of tumor necro-
sis factor signaling; it will be interesting to assess such signaling
capacity of molecular ensembles and cellular networks for
imprinting conformational barcodes.
Conformational barcodes and classical barcode descriptions,
such as the DNA barcode encoding genetic information, DNA
methylation, and the histone code in epigenetic regulation or
the stress history determining subsequent cellular responses
(Polman et al., 2012), all integrate changes of a large number of
parameters at the molecular and the cellular network levels.
However, conformational barcodes are much more general and
dynamic than the classical barcodes. A few recent publications
describe the barcode of G protein-coupled receptor (GPCR)
phosphorylation patterns (Butcher et al., 2011; Liggett, 2011;
Nobles et al., 2011; Reiter et al., 2012). Our description general-
izes these concepts to all cellular functions and accounts for
events other than phosphorylation; all determine the functional
response. The conformational barcode concept provides a gen-
eral view of how the cell decodes multiple co-occurring events.
All components of an allosteric barcode merge and coopera-
tively determine the shape of a protein functional site. In turn,
the functional site selects a partner whose shape is most favor-
able, thereby biasing the pathway in the direction of this partner,
while quenching others. This leads to a population shift in the
partner (Ma et al., 1999; Tsai et al., 1999). The subsequent
change in the partner’s shape may induce additional allosteric
events, such as a distinct phosphorylation pattern and binding,
which collectively create a new barcode that stimulates specific
downstream signaling through the partner. In vivo, in the
absence of an agonist, receptors may oscillate between their
inactive and active states. The equilibrium typically (though not
always) favors the inactive state, and in the absence of an
agonist, the time spent in the active state is short. Binding of
the agonist stabilizes the high energy active state, which leads
to a population shift toward this conformation. Posttranslational
modification enzymes (e.g., kinases, acetylases, methylases,
etc.) may recognize this populated conformation. PTMs can be
allosteric (i.e., away from the binding site) or at the binding site
(Figure 1; Nussinov et al., 2012). Their collective outcome will
translate into a specific shape, whichwill selectively bind another
protein, with a subsequent population shift. Each conformation
of the receptor can select an agonist that is most favorable to
its shape and chemistry. In turn, this more populated receptor
conformation, which differs from the first, will lead to an altered
pattern of posttranslational modification and binding events
and different pathways. Agonists may include proteins, RNA,
DNA, lipids, small ligands, such as drugs, ions (Liu et al.,
2012), light, and changes in pH that will affect protonation states;
all are also allosteric effectors.eserved
Figure 2. The Concept of a Conformational
Barcode
A barcode is a readable representation of data
relating to the object to which it is attached. Linear,
or 1D, barcodes represent data by varying the
widths of parallel lines and the spaces between
them; geometric patterns in 2D can employ rect-
angles and various combinations, including
hexagons. Protein-binding site barcodes are high-
dimensional.
(A) illustrates two acetylation marks (double or-
thosteric PTMs) on a histone H4 tail (red) recog-
nized by the bromodomain (BD1) of Brdt (green), a
testis-specific member of the BET protein family
(Protein Data Bank [PDB] 2WP2; Morinie`re et al.,
2009). That BD1 fails to bind monoacetylated H4
tail illustrates the essential role of combinatorial
PTM barcode in interaction specificity. The acet-
ylated lysines at positions 5 and 8 are shown.
(B) highlights the role of a barcode in the cellular
network. Proteins are depicted as nodes and interactions as edges. Some proteins (hubs) can have a large number of partners. A shared binding site of a hub
protein can bind multiple partners. Proteins with similar color edges (purple or green) share the same site. Binding of a specific protein determines the signaling
pathway. The binding event that takes place at a given time is largely governed by the barcode at the shared binding site.
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barcode tags along pathways in the cell. A conformational bar-
code is the result of the unification of all allosteric events acting
on a protein at a given time, collectively shifting its conforma-
tional ensemble and, by so doing, determining its functional
site shape and dynamics. A protein can have many conforma-
tional barcodes; these can be the outcome of physiological regu-
lation and allosteric, disease-related events (Nussinov and Tsai,
2013). Below, we relate to and provide examples of both.
Conformational barcodes are important because they describe
how the combinations of all allosteric events—beyond the
PTMs, which to date were credited as defining barcodes—are
read by partners and, as such, can explain pathway switching
and cell fates.
What Is a Barcode?
The classical definition of a barcode is an optical machine-read-
able representation of data relating to the object to which it is
attached. Linear, or one-dimensional (1D) barcodes represent
data by varying the widths of parallel lines and the spaces
between them. Geometric patterns in two dimensions (2D),
such as rectangles and hexagons, are also increasingly common
(Figure 2A). Optical bar code scanners read and interpret the
code. Because there are many ways to construct and arrange
the shapes and spaces, numerous symbologies are possible;
each provides unique information. The scanned data are trans-
mitted and relayed for an appropriate application.
Translating it to proteins, each functional site shape can be
viewed as a barcode, as in the case of the histone recognition
code (Musselman et al., 2012); each shape recognizes a specific
ligand. The classical barcode concept relates to PTMs that are at
the functional site. The histone barcode description captures
multiple different PTM combinations in the same (10–15 amino
acids) segment of protein sequence. Such a barcode concept
applies to direct recognition, where phosphorylation, acetyla-
tion, and methylation are all occurring within the same short
stretch of sequence. In contrast, allosteric barcode encom-
passes a much larger part of the protein. For example, b-arrestin
2 sites, which are phosphorylated by GRK2 (i.e., T360, S364,
S396, S401, S407, and S411), are responsible for GPCR internal-Structureization (Reiter et al., 2012). Thus, while some PTMs may be
located in a short sequence stretch and be directly recognized,
others are across the molecule and may work via long range
conformational effects, and in still other proteins, the effects of
both types may combine. Allosteric barcodes may further inte-
grate effectors other than PTMs.
Binding-site shapes are encoded by two major elements: allo-
steric events away from the binding site and posttranslational
modifications at the binding site, which, following the drug termi-
nology, we call ‘‘orthosteric PTMs.’’ Protein recognition domains
provide examples where these PTMs are read directly. Figure 1A
presents an example relating to serine phosphorylation barco-
des. Here, with the exception of the phosphorylation events at
the N-terminal, which prevent p53-MDM2 interaction far away,
all others are orthosteric and thus recognized directly. However,
the consequences of these binding events may also be allo-
steric. The shape is determined by the collective outcome of all
concomitant orthosteric PTMs and allosteric events. Because
the number of possible PTMs is large (over 300; Nussinov
et al., 2012), and the number of partners binding noncovalently
to a given protein, particularly receptors and signaling proteins,
can also be large, in principle, the number of possible codes
can be very large. Each shape can encode a specific function.
The barcode is likely to change in the presence of allosteric
gain-of-function mutations. By selecting one specific partner
over another (Figure 2B), this variability of the barcodes in a spe-
cific protein can control branching and integration of signaling
pathways and, in this way, spell cellular response. In the pres-
ence of gain-of-function mutations, shifting the pathway may
lead to drug resistance.
Functional sites provide conformational barcodes, each of
which is an intracellular address label. These conformational
barcodes differ from the ‘‘conventional’’ barcodes in four ways:
first, in the types of symbology that can be employed (i.e.,
conformational features instead of combinations of simple geo-
metric shapes); second, rather than a series of symbols that are
read and integrated, a conformational barcode and the chemis-
try that it presents (charged groups, hydrogen bonds, hydropho-
bic patches, etc.) cannot be separated into distinct components.
It is one unit that has to fit well and get selected. Third, the21, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1511
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Figure 3. Schematic Illustrations of Binding
by ‘‘Lock and Key,’’ ‘‘Induced Fit,’’ and
‘‘Conformational Selection’’ Models
(A) In (A), the drawing emphasizes the fact that the
lock and key model only allows a binding to
happen with an exact fit between complementary
geometric shapes of ligand and receptor. The
cross bar drawn in between implies no ligand-re-
ceptor binding can occur. Either the case of a re-
ceptor selecting among different ligands or the
reverse of a ligand selecting among different re-
ceptors are depicted, with the binding exclusively
determined by the exact lock-and-key fit criterion.
(B and C) Different colors imply different receptors.
In contrast to the lock and keymodel, the ‘‘induced
fit’’ model highlighted in (B) indicates that there is
no exact fit in the prebinding conformation be-
tween the ligand and receptor, as shown by the
cross bar on the receptor fitted exactly to the
ligand, and the consequent binding ends up with
the receptor being induced to change the shape to
fit into that of ligand. In the ‘‘conformational se-
lection’’ model, the emphasis of the illustration in
(C) is placed on the availability of pre-existing,
different receptor conformations, and the ligand
selects and binds the receptor via the lock and key
criterion. Here, different conformations of the
same receptor are in the same color (green). The
figure emphasizes that the lock-and-key hypoth-
esis considers many different receptor molecules.
Each receptor has one specific structure. One of
the receptor molecules (lock) fits the ligand (key).
In contrast, in conformational selection, the
ensemble consists of many distinct conformations
of the same receptor molecule.
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conformational dynamics can be a critical component of the bar-
code. A conformational barcode does not necessarily consist of
a structural change; it can be represented by changes in shape
and dynamics or only by changes in the molecular fluctuations.
Thus, unlike the 1D (or 2D) conventional barcodes, conforma-
tional barcodes are high-dimensional. Mechanistically, they
may reflect protein frustration (Zhuravlev and Papoian, 2010),
dynamic prestress, and dynamic changes in the rigidity of pro-
tein structures (Csermely et al., 2013; Ga´spa´r and Csermely,
2012). All tally to the high dimensionality.
Unlike the ‘‘conventional barcodes,’’ where the optical
machine-readable representation of data is translated into a
set of numbers, our conformational barcode description lacks
quantitation. Quantifying the collective effects of all co-occurring
allosteric events, including gain-of-function mutations, is chal-
lenging. Nonetheless, allosteric barcodes are useful in providing
a comprehensive framework of the cellular network from the
functional standpoint, helping to understand how allosteric
events can contribute to pathway divergence.
Barcodes Are the Result of Population Shift
In vivo, signaling can initiate or be altered by noncovalent binding
and covalent posttranslational modifications. Three theories
have been proposed to explain molecular recognition and bind-
ing in signaling (Figure 3). The first was the ‘‘lock and key’’ mech-
anism, which considered the protein and the ligand as rigid
molecules that require precise conformational match to form a
functional complex. The ‘‘lock and key’’ mechanism is unable
to explain the heterogeneity of the recognition where one recep-
tor is able to bind at the same site multiple different ligands, as in1512 Structure 21, September 3, 2013 ª2013 Elsevier Ltd All rights rthe case of the EphA4 receptor and the nine ephrin ligands
(Lackmann and Boyd, 2008); it is also unable to explain the mod-
ulation of the signaling in the pathway. The second was the
‘‘induced fit’’ hypothesis, which argues that, in complexes, the
partners may have different conformations from those observed
in their unbound states and that those bound conformations are
‘‘induced’’ by the binding partners. However, a large body of
experimental (Boehr et al., 2009) and computational (Long and
Bru¨schweiler, 2011b; Wlodarski and Zagrovic, 2009) data indi-
cate that the bound state conformation already exists before
binding. In the late 1990s, we proposed a third theory, that of
the ‘‘conformational selection and population shift’’ (Tsai et al.,
1999). This theory recognized that biological macromolecules
pre-exist in a broad range of conformations, among which are
the bound state conformers, and suggested that the most com-
plementary conformer binds, followed by population shift of the
ensemble to restore the equilibrium. Conformational transitions
between the species determine the time scales of the population
shift for the binding reaction. The higher the barriers that need to
be overcome in the conformational transitions, the slower the
population shift. Conformational selection is followed by induced
fit, which involves minor backbone and side-chain conforma-
tional changes to optimize the interaction (Csermely et al.,
2010). We further proposed (Ma et al., 1999; Tsai et al., 1999)
that evolution exploited the pre-existing conformations and
optimized and tuned them for cellular life. Thus, the concepts
of the pre-existence of all functional conformational states,
which allows conformational selection, and of the population
shift are powerful in explaining functional mechanisms. They
also relate binding to population shift in allosteric transitions.
Conformational selection and population shift take place ineserved
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Reviewprotein-protein interactions, protein-RNA, and protein-DNA.
They are important in protein-small molecule binding, including
drugs and metabolites, and in binding of lipids. All can induce
allosteric propagation.
In a similarmanner, signalingmay start from aPTMevent. PTM
is a covalent linkage of a chemical group on the protein surface.
The enzymatic reaction can take place during or following pro-
tein synthesis. PTMs can be small or large, hydrophobic or
charged. They range from phosphate group, acetyl, methyl, to
a fatty acid moiety, and to a peptide, such as ubiquitin or ubiqui-
tin-like chains, like Sumo. PTMs can take place at the binding
site, in which case they are directly recognized by recognition
domains, or elsewhere on the protein surface, in which case
they act allosterically. The perturbation to the protein target
caused by covalent binding is expected to be at least as large
as that incurred by noncovalent binding. PTM events can also
take place on nucleic acids, for example, DNAmethylation. Pop-
ulation shift explains cooperativity, and barcodes are the result
of population shift following such perturbation events.
Allosteric Barcodes: Origins and Consequences
The structural details and the contacts that the partners make,
even when binding a shared site, differ; thus, the allosteric con-
sequences vary. Each event initiates a distinct distribution of
allosteric pathways and may result in (slightly) different binding
site shape and dynamics, which may affect the selection of a
binding partner elsewhere and the affinity of that interaction.
Since proteins can bind multiple partners simultaneously, as,
for example, in the case of transcription factors, a large number
of possible combinatorial effectsmay result. The partners are not
necessarily proteins: they can be DNA or RNA; small signaling
second messengers, such as cyclic adenosine monophosphate
(cAMP); ATP/GTP, nicotinamide adenine dinucleotide (NAD)/
reduced NAD, or flavin adenine dinucleotide; or ions (e.g., Ca2+
and Zn2+) or lipids, etc.; the effects can be compounded by
physical environmental factors. Since some (hub) proteins can
have tens or hundreds of partners, the number of combinations
can be very large.
The multiple PTM types and sites in a protein can further
contribute to make the number of possible combinatorial allo-
steric outcomes vast. There are hundreds of PTM types, some
small (e.g., hydroxylation and methylation), some large (ubiquiti-
nation), some charged (phosphorylation and acetylation), some
hydrophobic (alkylation and myristoylation), and some involving
sugars. PTMs are common, and a site may be modified by
several PTM types. PTM addition and removal can result in a
huge number of possible combinations, which serve to expand
the functional breadth of the proteins in pathway modulation.
For example, transcription factor p53 contains at least 50 PTM
sites (Meek and Anderson, 2009); the FoxO family of Forkhead
transcription factors undergoes phosphorylation, acetylation,
and ubiquitination, with distinct PTM combinations acting as
specific codes. Seventeen potential PTM sites were found in
FOXO3a, and it was suggested that single and binary modifica-
tions could result in up to 131 072 (217) distinct PTM patterns
(Benayoun and Veitia, 2009). Because the perturbation caused
by each type of PTM is different and also depends on the protein
structural environment, the range of collective variations in the
population shift as expressed by the allosteric effect at the func-Structuretional site is very large.Combinedwith simultaneous noncovalent
binding events, they can code for specific functions. Figure 4
illustrates schematically possible scenarios where PTMs with
different volumes (e.g., methylation versus ubiquitination), chem-
ical properties (e.g., the negatively charged phosphate or acetyl
group versus palmitoylation, farnesylation, or alkylation), protein
structural environments, and combinations, together with non-
covalent events, can lead to large variation in a shared binding
site, leading it to preferentially select a certain partner over
another. These scenarios are described via detailed examples.
Taken together, this argues for an allosteric barcode where
each combination defines a distinct function. An enormously
challenging goal is to spell out the functional outcome of specific
combinations. The complexities of the tasks are huge; insights
into the allosteric conformational barcode will be extremely use-
ful in forecasting consequences of deleterious mutations and of
drug regimens not only on the protein but on the pathway level
(Lee et al., 2012). Binding of an allosteric drug similarly defines
an allosteric barcode at the active site elsewhere.
Allosteric Effects Propagate Across Protein Interfaces
Population shift occurs across proteins (Lee et al., 2008); it spans
their interactions with other proteins (Boehr, 2012; Boehr et al.,
2009; Lee et al., 2008; Long andBru¨schweiler, 2011a;Mackereth
et al., 2011; Moal and Bates, 2012), DNA/RNA (Fuxreiter et al.,
2011), and lipids along the pathways (Antal et al., 2009; Nussinov
et al., 2011) and throughout the cell (Nussinov and Tsai, 2013;
Nussinov et al., 2013b). Propagation takes place across multi-
molecular complexes, in the membrane, cytoplasm, and organ-
elles, as, for example, in the ligase, proteasome, ribosome,
where propagation can span proteins and RNA, and chromatin
remodeling complexes. These illustrate how allosteric effects
encoded by address labels can relay signals across domain
and molecular boundaries.
Propagation across Obligate Interactions CanBeHelped
by Molecular Disorder
Obligate protein-protein complexes typically involve interfaces
with large buried surface areas and tight binding. Propagation
is expected to be efficient when the interfaces are tightly packed.
This could be particularly the case if the unbound states of pro-
teins are disordered and couple binding and folding (Tsai and
Nussinov, 1997, 2011). Disordered proteins (domains) are
frequent components of large multimolecular complexes. One
example is the 26 subunit Mediator complex, which consists of
three modules: tail, middle, and head. Mediator mediates long
range signaling between DNA regulatory elements (REs) bound
to transcription factors (TFs), the RNA polymerase II (Pol II),
and the basal transcription factors. The TF-bound gene-specific
REs can be far from transcription start sites. The DNA is an allo-
steric effector; its binding to the DNA-binding domain of a TF
results in allosteric perturbation that propagates to the activation
domain of the TF, which can then bind to the tail/middle or head
modules of Mediator. The allosteric propagation pathways pro-
ceed through the TF-Mediator interface and across the gigantic
Mediator and its multiple subunit interfaces. Cryo-EM images
illustrate that the outcome is allosteric ‘‘shape-shifting’’ of sub-
units (MED17,MED18, andMED20) in theMediator headmodule
400 A˚ away, leading to a jaw-like opening of the head, which
then interacts with the basal transcription factors and RNA Pol21, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1513
Figure 4. Schematic Diagrams of Allosteric PTM Examples
(A) illustrates an active thyroid hormone-activating type 2 deiodinase with a bound T4 substrate. It is transiently inactivated by ubiquitylation at the dimer interface.
The allosteric action of the ubiquitylations is illustrated by the interacting blue ellipsoids, which propagate the steric hindrance down to the T4 binding site (Sagar
et al., 2007).
(B) Progressive phosphorylation events up to a certain threshold number at the N-terminal region of circadian clock protein, FRQ, allosterically expose its
protected middle region (purple circle) and lead to its own degradation (Querfurth et al., 2011). The allosteric action is illustrated by the interacting blue ellipsoids,
which propagate the created electrostatic repulsion between the N-terminal and C-terminal of FRQ down to the exposed middle region (orange circle).
(C–E) A phosphorylation-dependent activation of c-Cbl, a RING ubiquitin ligase that attenuate receptor tyrosine kinase signal transduction, is illustrated by four
captured crystal structures with a combination of two involved allosteric actions. (C) provides amodel for the binding of substrate sequences (the ZAP-70 peptide)
to the N-terminal SH2-containing tyrosine kinase-binding domain (TKBD) and of ubiquitin-conjugating enzyme (E2) and Tyr371 phosphorylation, together leading
toward c-Cbl activation (Dou et al., 2012). In the absence of E2 and the TKBD substrate, the c-CBl (a single-subunit RING E3 that negatively regulates proteins by
promoting ubiquitination and subsequent degradation; PDB 2Y1M) adopts a closed conformation, in which the E2-binding surface of RING subdomain asso-
ciates with the TKBD. The allosteric effect of the ZAP-70 peptide binding partially opens the RING subdomain, making it favorable for E2 binding. This is clearly
seen from the superposition of the two crystal structures (PDB 2Y1M and 2Y1N) shown in (D), which indicate the partial RING opening (the RINGmovement from
red to green) due to the TKBD substrate binding (yellow ribbon). The subsequent E2 binding causes the RING subdomain to adopt an open conformation. Tyr371,
whichmediates the linker helix region (LHR) subdomain binding to the TKBD, secures the c-Cbl in an inactive state. The phosphorylation of Tyr371 activates c-Cbl
by releasing LHR from TKBD, which then undergoes a large conformational change that brings the RING subdomain and E2 into proximity of the substrate. The
large conformational change due to the pTyr371 is seen from the superposition of two crystal structures (PDB 1FBV and 4A4C) in (E). Both the side chains of
Tyr371 (red) and pTyr371 (green) are given in space-fill models. (A) and (B) are adapted with permission from Nussinov et al., (2012).
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ReviewII (Cai et al., 2010). ‘‘Shape-shifting’’ is observed when a large
conformational change is displayed by a sufficiently high popu-
lation in the ensemble (Tsai and Nussinov, 1997). Thus, the
perturbation by the binding of the TF activation domain causes
a significant conformational change that propagates via Medi-
ator head to RNA Pol II subunits Rpb4/Rpb7 and finally to the
clamp of Pol II to initiate/activate transcription. Bioinformatics
analysis found that: (1) the conformational disorder level of the
Mediator exceeds that in other complexes of similar size (Cai
et al., 2010); (2) disorder is particularly high in the tail and middle
modules, which emerged more recently; (3) the extent of disor-
der increases through evolution (from yeast to human); and (4)
the disordered regions arrangements and interaction sites are1514 Structure 21, September 3, 2013 ª2013 Elsevier Ltd All rights rsimilar between yeast and human, which indicates specific
recognition at protein-protein interfaces, as further corroborated
by available crystal structure data (Seizl et al., 2011). The
different DNA sequences of the DNA REs selectively bind the
complementary conformation of the functional site on the TF
DNA-binding domain. The subsequent population shift allosteri-
cally stamps address labels on the TF activation domains (AD). In
p53, activating domain (p53AD) and p53 C-terminal domain
(p53CTD) interact with MED17 and MED1, respectively, and
these interactions affect Mediator structure and Pol II activity
(p53AD induces pocket formation in MED17 and this correlates
with activation of stalled Pol II, which is not the case for the
p53CTD-MED1 interaction). Gain-of-function mutations ofeserved
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tion and thus Pol II binding, apparently due to Mediator’s
shape-shifting, which in turn is the outcome of a conformational
change in the p53AD binding site (Meyer et al., 2010).
Disorder is frequent in proteins involved in cell signaling
(Iakoucheva et al., 2002; Zhou, 2012). Analysis of a database
of signaling proteins found that there is significantly more pre-
dicted disorder in signaling and cancer-associated proteins
than in several other categories of protein function, such as
metabolism, biosynthesis, and degradation. Because in disor-
dered states the differences in energy among the states can
be small and the barriers separating them low, they might be
more sensitive to barcode combinations.
Propagation Takes Place across Transient, Dynamic
Interactions
Interfaces of short-lived interactions are usually small and often
with a limited region of tight packing. This does not hamper allo-
steric propagation, which can proceed even through small
chemical groups; a striking recent example has shown that small
variation in a ligand is sufficient to transform an agonist into an
antagonist (Sadowsky et al., 2011). That small structural vari-
ability can lead to alteration in the allosteric signals can also be
seen by mutations. Regulation and crosstalk between pathways
largely take place via short-lived interactions. The molecules (or
preformed complexes) bind, initiate or transmit the signal, and
dissociate, followed by other binding events, as, for example,
in the case of Ras protein (a guanosine triphosphatase
[GTPase]), which controls the cell growth and differentiation
signaling pathways. Ras forms transient complexes with
GTPase-activating proteins (GAPs) switching it OFF and with
guanine nucleotide-exchange factors switching it ON when the
cell is activated or resting in response to stimuli, respectively.
The key point is the binding kinetics: so long as the protein-
protein (or ligand) residence time is sufficient for the allosteric
propagation wave to go through, the association will be produc-
tive in signaling (Stein et al., 2009).
Propagation across Domains
Domain boundaries resemble intermolecular boundaries, and
allosteric effects also propagate across domain borders. We
cited above the propagation between a TF DNA binding domain
and the activation domain; another striking recent example is
that of the androgen receptor (AR). There, a study inspired by
mutations related to the androgen insensitivity syndromes
and prostate cancer observed that AR-ligand-binding domain
mutations D695N, R710A, F754S, and P766A induced a
decrease in DNA binding but left the ligand binding unaffected;
however, DNA-binding domain mutations K590A, K592A, and
E621A lowered the ligand binding affinity but not DNA binding
(Helsen et al., 2012).
Allosteric Conformational Switches via Phosphorylation
Barcodes: The Kinase-Mediated Phosphorylation of
GPCRs Example
GPCRs sense extramembranous molecules, such as neuro-
transmitters, hormones, and pheromones, whose binding acti-
vates signaling pathways and cellular responses. GPCRs exist
in a broad range of conformational states. In the absence of
the ligand agonist, they fluctuate between the active and the
more highly populated inactive conformations. Agonist bindingStructureselectively stabilizes one of the active GPCR conformations,
which leads to a population shift. A different agonist may stabi-
lize another. Heteromeric G protein recognizes a specific
agonist-bound state. The dissociation of its a or b and g subunits
signals to effectors such as adenylyl cyclase, leading to a change
in the concentration of second messenger cAMP, which affects
cellular function. However, with continuous agonist binding,
GPCR signaling wanes, becoming desensitized. Desensitization
takes place via phosphorylation by GPCR kinases (GRKs), often
at the GPCRs’ Ser or Thr residues in the third intracellular loop or
in the cytoplasmic tail (there are 11 Ser and Thr residues in the
cytoplasmic tail of b2AR), which are at the binding sites of the
G proteins. Many possible combinations of Ser and Thr phos-
phorylation patterns can be obtained, each the result of a
different GRK (e.g., GRK2 or GRK6), which likely favor binding
to a distinct populated GPCR ligand-bound conformation. The
phosphorylated GPCRs become substrates for b-arrestins,
which not only partially quench G protein binding but can sti-
mulate signaling through the action of the b-arrestin scaffolds.
Distinct phosphorylation patterns may select specific b-arrestin
conformations; in turn, each b-arrestin conformation can select
its specific partner and, in this way, the effect influences
downstream signaling via the b-arrestins. b-arrestins serve as
multiprotein scaffolds, regulating a large number of signaling
molecules, including the MAPKs ERK, c-Jun N-terminal kinase
(JNK), and p38 as well as Akt, PI3 kinase, and RhoA. For
example, b-arrestin1 can recruit c-Src, a nonreceptor tyrosine
kinase family member, to 7TMRs. Src recruitment to the b2AR
leads to ERK activation. b-arrestin2 scaffolds appear to act in
ERK activation by mediating binding of ERK1/2 and Raf1 and
MEK-1. ERK1/2 and Raf-1 bind b-arrestin2 directly, and the
mitogen-activated protein kinase kinase MEK-1 binds indirectly.
The b-arrestin scaffold also mediates JNK3 activation. Similar to
ERK, JNK3 and apoptosis signaling kinase 1 all bind b-arrestin2
directly, whereas MAP kinase kinase 4 binds indirectly (DeWire
et al., 2007). A different conformation of b-arrestin2 is likely to
be involved in each pathway (Xiao et al., 2004).
These downstream signals are configured by b-arrestin
conformations, which are specified by the GRK barcoding phos-
phorylation patterns on the receptors (Butcher et al., 2011; Lig-
gett, 2011; Nobles et al., 2011). Each GRK can phosphorylate
different serine and threonine residues on a given ligand-bound
receptor conformation. Thus, ligand binding biases the GPCR
ensemble, which is read by the GRKs. The GRKs redistribute
the population of the phosphorylated GPCRs, tagging them by
new barcodes. These are read by the ensemble of the b-arrest-
ins. The pattern of GRK phosphorylation sites and the selection
of the conformation of b-arrestin can differ substantially, even
among closely related GPCRs that are stimulated by the same
agonist, which can further diversify its effect on downstream
signaling (Nussinov et al., 2013b).
How Diversified Allosteric Barcodes Establish Distinct
Types of Molecular Switches: Conformational Switches
in the Kinases
Conformational switches do not always involve allosteric
effects (Bradshaw, 2010). The Src, Syk, and Tec types of molec-
ular switches provide examples (Figure 5; Bradshaw, 2010;
Deindl et al., 2007; Filippakopoulos et al., 2008; Jura et al.,21, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1515
Figure 5. An Illustration of Distinct Molecular Switches that Can Be
Decided by the Diverse Allosteric Barcodes in Cytoplasmic Tyrosine
Kinases
(A) These barcodes are expressed by three catalytic regulation mechanisms.
These include (1) orthosteric phosphorylation of Tyr residues in the activation
loop; (2) allosteric activation through binding at the N-lobe of kinase core
domain; and (3) autoinhibitory binding at various allosteric sites. The first two
regulation events are revealed in (A) with the example of active Fes kinase
conformation (PDB 3CD3). The active site of Fes kinase is shown in the cleft
between N-lobe (green) and C-lobe (yellow) subdomains, with the aC-helix
positioned by the SH2 (red) subdomain in an active orientation as well as the
activation loop, which is organized by the orthosteric phosphorylation of
pY713 to an active configuration. The allosteric intramolecular interactions are
highlighted by the tight electrostatic interactions between residues Glu (E469
and E472) in SH2 and Arg (R609) in aC-helix.
(B andC) The third autoinhibitory regulation event is depicted in (B) and (C) with
the examples of Src and Syk kinase, respectively. In (B), the inactive Src kinase
(PDB 1FMK) is superimposed onto an active kinase (PDB 1YI6) with an
orthosteric phosphorylation (pTyr416). When compared to the (superimposed)
active kinase (orange), the disoriented N-lobe (yellow) from the inactive Src
kinase reveals that the autoinhibitory mechanism is through the intramolecular
SH3 (red) binding to the kinase N-lobe, mediated by the SH2-kinase linker
(white). The autoinhibitory mechanism is also helped by the SH2 (green)
binding to the kinase C-terminal through the phosphorylated Tyr (pTyr527). In
(C), the inactive Syk kinase Zap-70 (PDB 2OZO) is superimposed on an active
kinase (PDB 1U59) with dual orthosteric phosphorylation events (Y492 and
Y493) and by an ITAM peptide (PDB 2OQ1) bound to both SH2 domains. The
autoinhibitory mechanism suggested that the rigidification of SH2-kinase
linker (blue) is due to the interaction with inter-SH2 linker (green), which
reduces kinase flexibility at the catalytic cleft. Therefore, the activation of Syk
kinase can be achieved either through the phosphorylation within SH2-kinase
linker (pY315 and pY319) or binding of phosphorylated ITAM peptide (light
green) with the two highlighted phosphorylated Tyr to the tandem SH2 sub-
domains. The mechanism of the disrupting interactions between inter-SH2
linker and SH2-kinase linker in the former action is orthosteric and is allosteric
in the latter. See text for further detailed description of distinct molecular
switches observed in cytoplasmic tyrosine kinases.
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large family which constitutes almost 2% of the human genome,
possess a very similar enzymatic core domain, with the active
site located at the cleft between its N-lobe and C-lobe subdo-
mains (Figure 5A). It has been well established that all kinase
catalytic activities are regulated through three core actions: (1)
orthosteric phosphorylation of key residues located in the activa-
tion loop for organizing and/or stabilizing the active conforma-
tion; (2) allosteric binding via intra- or inter molecular interactions
in the N-lobe (such as the PIF binding pocket) to position the aC-
helix in an active configuration; and (3) autoinhibitory binding at
various allosteric sites to suppress kinase activity. Figure 5A
highlights theorthosteric phosphorylation and the allosteric intra-
molecular interaction in the Fes kinase. The phosphorylated Tyr
(pY713) in the activation loop aswell as the tight binding between
theSH2domain and theaC-helix due to electrostatic interactions
between Glu (E469 and E472) and Arg (R609) residues are indi-
cated in the figure. Figures 5B and 5C depict crystal structures
of suppressed kinase activity, respectively, for the Src kinase
and the Syk kinase Zap-70. In Figure 5B, the conformation of
inactive Src kinase was superimposed on an active kinase core
domain with an orthosteric phosphorylation (pTyr416), revealing
a disorientated N-lobe in the inactive kinase. The reason for the
distorted kinase domain appears to be due to the intramolecular
SH3 binding, mediated by the SH2-kinase linker that interacts
with kinaseN-lobe. Also highlighted in Figure 5B is the phosphor-
ylated Tyr at the kinase C-terminal (pTyr527) bound to the SH2
domain, which plays a significant role in stabilizing the intramo-
lecular SH3 binding. In Figure 5C, the Syk family kinase Zap-70eserved
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similar organization but different mechanism as compared to the
case of Src kinase above. In contrast to Src, not much distortion
in the N-lobe is observed based on the superposition to an active
Syk kinase with dual orthosteric phosphorylation (Y492 and
Y493). Therefore, it has been suggested that rigidification of the
SH2-kinase linker, due to the interaction with inter-SH2 linker,
is responsible for autoinhibition in Zap-70 by reducing kinase
flexibility at the catalytic cleft.
Cytoplasmic (also known as nonreceptor) tyrosine kinases, the
Src, Syk, and Tec kinase families, are essential for signaling of
antigen and Fc receptors in hematopoietic cells. Current data
suggest that regulation can take place via three types of
switches: Src kinase activation functions as a graded switch;
Syk kinase activation as anOR-gate switch; and Tec kinase acti-
vation as an AND-gate switch. Here, we illustrate how diversified
allosteric barcodes establish distinct types of molecular
switches. An ideal graded switch can be defined as one where
(1) the partial contributions of events toward activation are
always additive and (2) full activity requires all contributions
from every activation event. The Src kinase has been shown to
incrementally increase its enzymatic activity with individual allo-
steric autoinhibition disruption events, such as dephosphoryla-
tion of the C-terminal tail (pY527; Figure 5B) and ligand binding
either to the SH2 subdomain or to the SH3 subdomain, as well
as orthosteric phosphorylation within the activation loop
(pY416; Figure 5B). The definition of an OR-gate switch, as the
name suggests, requires only one single activation event to
reach full activity. The Syk kinases reach full activity through an
allosteric autoinhibition disruption event: either the binding of
phosphorylated immunoreceptor tyrosine-based activation
motif (ITAM) peptide to the tandem SH2 subdomains
(Figure 5C) or phosphorylation within the SH2-kinase linker
(pY315 and pY319; Figure 5C). The AND-gate is switched on in
an all-or-none fashion only after all activation events. Current
data suggest that, to have high activity, the Tec kinase requires
both activation loop phosphorylation and docking of the SH2-
kinase linker against the kinase (with a similar mechanism to
that shown in Figure 5A; Bradshaw, 2010).
Why do they function as distinct types of switches, even
though the Src, Syk, and Tec in the cytoplasmic tyrosine kinase
family have similar kinase core domain and similar full chain
arrangement (with additional SH2 and SH3 subdomains)? Struc-
tural insight into the allosteric barcodes may provide answers.
First, although the core domains among kinase families are
very similar, evolution has ascribed different choices of activa-
tion events in different families. For Syk kinase, in addition to
the role of organizing the activation loop in the active conforma-
tion, orthosteric phosphorylation is also able to propagate local
environmental changes to remotely position the aC-helix in an
active configuration. Therefore, when the autoinhibition interac-
tion is disrupted either by orthosteric phosphorylation events
within the SH2-kinase linker (pY315 and pY319) or by an allo-
steric ITAM binding, the autophosphorylation (pY491 and
pY493) within the activation loop is able to fully activate the
Syk kinase. For the AND-gate switch, the activation of the Tec
kinase simply requires well-built cooperativity among all activa-
tion events in order to shift the dominant kinase population
toward the active conformation. Note that no negative autoinhi-Structurebition disruption action is involved in the Tec kinase case, only
positive activation. In a graded switch, a single activation
event—whether a disrupted or formed interaction—is unable to
shift the active kinase conformation tomake it the dominant pop-
ulation in the ensemble. Instead, each activation event adds in a
step-by-step manner to shift the most favorable conformation
toward the active state.
Conformational Barcodes, Diseases, and Allosteric
Drug Therapeutics
Diseases can be caused by external pathogens, such as bacte-
ria, fungi, viruses, protozoa, multicellular organisms, and aber-
rant proteins, such as prions, or by internal dysfunction.
Mutations that lead to failure to produce proteins in correct
amounts—too low or too high—can disrupt metabolic or regula-
tory signaling pathways. Binding of pathogens, gain-of-function
mutations, the sun, and irradiation can all have a key role in
shaping barcodes, impacting molecular recognition and, thus,
cellular pathways (Nussinov and Tsai, 2013).
Binding of Pathogens
Allosteric binding of pathogen proteins may interfere with regu-
lated signaling and lead to disease by similarly causing a
population shift. Oncogenic proteins E6 and E7 of human papil-
lomavirus (HPV) provide one example. E6 binds host regulatory
proteins, such as p53 and SAP97, and mark these proteins for
destruction. E6 binds simultaneously to the three PDZ domains
of SAP97 in vitro, leading to their reorganization. Nuclear mag-
netic resonance experiments detected residues in PDZ2 that
are not part of the peptide-binding pocket but experience chem-
ical shift changes upon binding of E6 through an intradomain
allosteric effect, whichmaymodulate SAP97 binding to a partner
(Chi et al., 2011). A mutant E6 protein lacking the PDZ-binding
motif is found at lower levels because of rapid degradation by
the proteasome (Nicolaides et al., 2011). Poliovirus (PV) provides
an example of a pathogen that initiates allosterically downstream
events, leading to cell death. In PV-infectedmice, motor neurons
undergo apoptosis by PV activation of Bax, a proapoptotic
member of the Bcl-2 family, mediated by JNK (Autret et al.,
2007). Bax activation involves a conformational change that
exposes the N-terminal of Bax, which leads to its translocation
from the cytosol to the mitochondria. Finally, an example is
related to apamin, an 18 amino acid peptide neurotoxin in api-
toxin (bee venom) whose allosteric effects deregulate channels.
Activation of small-conductance calcium Ca2+-dependent
potassium channels regulates membrane excitability. There
are three subtypes (SK1–SK3) in the nervous system, and apa-
min distinguishes between them. Apamin binds to a three amino
acid motif within the S3 to S4 extracellular loop to produce a
high-sensitivity allosteric block by regulating the shape of the
outer channel pore. Interestingly, the S3 to S4 loop of one sub-
unit in the heteromeric channel overlaps the outer pore of the
adjacent subunit (Weatherall et al., 2011). Heteromeric channels
are common, and allosteric effects can also be expected in other
cases.
UVB Exposure by Sunlight
Ultraviolet B (UVB)-induced DNA damage is the major agent in
neomelanoma skin cancer development, but there is increasing
evidence for a role for HPVs, including HPV 5 and HPV 8, in sun-
exposed body sites. Following UVB exposure, Bak undergoes a21, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1517
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inserted into a groove of another Bak monomer. This initiates
Bak oligomerization, which facilitates pore formation in the outer
mitochondrial membrane, leading to the release of proapoptotic
factors. The HPV E6 protein affects UVB-induced apoptosis, tar-
geting Bak for proteolytic degradation (Simmonds and Storey,
2008). The mechanism is again via a population shift.
Mutations
Most of the known mutations in proteins that have been associ-
ated with disease occur in binding (or active) sites. Active site
mutations can abolish, weaken, or alter an interaction or a cata-
lytic activity. There are numerous examples (e.g., the C133W
mutation in the active site of serine palmitoyltransferase [Gable
et al., 2010], active site mutation Y955C in mitochondrial DNA
polymerase g [Estep and Johnson, 2011], half of the mutations
in choline acetyl transferase that cause motor disorders are in
the active site [Cai et al., 2004], and Lowe syndrome and Dent
disease typically present such mutations in the OCRL protein
[Pirruccello et al., 2011]). Point mutations can also take place
at a PTM site, abolishing the modification and thus affecting
the recognition by a PTM recognition domain, also leading to
disease. A recent example is the mutation of H2BK123, which
abolishes Dam1 methylation (Latham et al., 2011). Finally, the
G201V mutation in the human proteasome subunit b-type 8
gene that encodes the immunoproteasome subunit b5i in
patients with Nakajo-Nishimura (NNS) syndrome, a distinct in-
flammatory andwasting disease, is in close proximity to the thre-
onine and lysine in the catalytic center and causes ubiquitinated
proteins to accumulate (Arima et al., 2011).
However, in reality, the majority of the gain-of-function muta-
tions are away from the active (or binding) site. For example,
the structure of the enzyme galactocerebrosidase (Deane
et al., 2011) illustrates that the Krabbe disease-causing muta-
tions, a devastating neurodegenerative disease, are widely
distributed throughout the protein. Dominant mutations in
glycyl-transfer RNA (tRNA) synthetase (GlyRS) and tyrosyl-
tRNA synthetase cause theCharcot-Marie-Tooth (CMT) disease,
the most common heritable disease of the peripheral nervous
system. The mutations are scattered in the structure and have
no apparent unifying connection (Xie et al., 2007). The structure
of CMT-causing mutant (G526R) of homodimeric human GlyRS
shows that the mutation is at the site of synthesis of glycyl-
adenylate; however, the effects are observed 30 A˚ away, at the
stabilized dimer interface. The choline acetyltransferase struc-
ture reveals a broad distribution of mutations that cause motor
disorders (Cai et al., 2004). Half of the mutations affect enzyme
activity directly; the others are distant from the active site and
exert indirect effects. In addition to the OCRL protein mutation
at the Rab5 binding site, Lowe syndrome and type 2 Dent dis-
ease-associated missense mutations affect the short phenylala-
nine and histidine motif indirectly by destabilizing the RhoGAP
fold (Pirruccello et al., 2011). In the NNS syndrome, the G201V
substitution caused conformational changes not only in Thr73
and Lys105 at the catalytic site; additional conformational
changes were observed in the S8–H3 loop located at the inter-
face between b4 and b5i, which impaired the assembly of the
20S proteasome (Arima et al., 2011).
In all of these cases, the mutations were away from the func-
tional site; the outcome of all leads to disease. The connection1518 Structure 21, September 3, 2013 ª2013 Elsevier Ltd All rights rbetween the mutations and the disease was attributed to
different possible causes. However, in all, allostery appears to
play a key unifying role by specifying the conformational bar-
code. Dysfunctional conformational barcodes in disease states
can be (partially) restored to their ‘‘healthy’’ barcode ensemble
states by allosteric drugs (Csermely et al., 2013; Nussinov
et al., 2011). Efficient, nontoxic modification of dysfunctional
conformational barcodes is a major challenge.
Conclusions
The cell is complex, and deciphering of its signal transduction is
challenging (Kiel and Serrano, 2012). Cellular diagrams illustrate
this complexity by dense, interconnected maps. Interconnectiv-
ity takes place through shared proteins. Such ‘‘hub,’’ or signaling
proteins, may have tens or even hundreds of partners. A key
question is then what decides pathway unification and diver-
gence? How does the signaling protein ‘‘know’’ which protein
to select at any given time? Such questions are critical to the
understanding of cell regulation. Here, our major tenet is that
the conformation of a binding site acts like a (high-dimensional)
barcode. This barcode is decided by the collective effects of
all allosteric events on the protein, including disease-related
ones, such as binding of pathogenic proteins, and gain-of-func-
tion mutations. From the free-energy landscape standpoint
(Frauenfelder et al., 1991), the combined outcome of all is stabi-
lization of a certain conformation; in so doing, the binding site in
this conformation becomes an intracellular address label,
providing a conformational barcode. The partner selected by
this conformational barcode decides the pathway direction,
and by not selecting other partners, alternate pathways are
quenched. A change in conditions will modify this allosteric
conformational barcode, resulting in another pathway taking
over. Insight into these questions may help in synthetic biology
approaches to signaling (Kiel et al., 2010). Because proteins
pre-exist in a broad range of states, all pathways pre-exist in
the cell. Those taking place via sparsely populated states do
so at the basal, unregulated levels and may or may not be
detected. Changes in conformational barcodes induced by
extracellular signaling, pathogens, gain-of-function and drug-
resistant mutations, and allosteric drugs can all rewire the
network, shifting the relative pathway occupancy, and, in this
way, transform ‘‘dormant’’ pathways into dominant ones.
This review aims to go beyond aggregating recent develop-
ments in the structural biology of allostery. It attempts to provide
unifying insights that bring to light emerging trends that may
otherwise remain latent and more elusive. In particular, it
stresses the importance of collectively evaluating all the multiple
co-occurring allosteric and orthosteric perturbations sensed by
a given receptor, as opposed to considering each single pertur-
bation in isolation. These perturbations are either covalent (e.g.,
mutations and/or PTMs) or noncovalent (e.g., effector or drug
binding or even UVB radiation). Each unique and time-depen-
dent combination of allosteric and orthosteric perturbations
results in a specific ‘‘molecular barcode,’’ defined in the context
of the free-energy landscape as a distinct set of populations of
protein states with specific structural and dynamical properties.
How different sets of perturbations map into different barcodes
or sets of populations depends on the type of allosteric
switch (i.e., graded switch versus OR- versus AND-gates), aseserved
Structure
Reviewexemplified by the Src, Syk, and Tec cytoplasmic tyrosine kinase
families.
The concept of ‘‘molecular barcode’’ has a well-defined
combinatorial connotation and, as such, its value is not only
semantic but much more substantial, as it may open new per-
spectives in the field of allostery, explaining the complexity and
diversity of signaling networks and stimulating new lines of
research. It argues for shifting the focus fromsingle allosteric per-
turbations considered in isolation to a more holistic approach, in
which multiple allosteric perturbations are simultaneously taken
into consideration in an integrative manner. In addition, the
concept of ‘‘molecular barcode’’ explains how a single allosteric
system serving as hub node in a complex signaling network
may initiate, relay, or terminate signal propagation. Themolecular
barcode treatment helps to explain how select signaling cas-
cades are favored over others, leading toward divergence or
convergence and eventually rewiring signaling pathways.
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